Hospitalized COVID-19 patients with diabetes represent more than 20
percent of ICU population

Date:
June 5, 2020
Source:
The Endocrine Society
Summary:
New guidance offers glucose management strategies that limit direct
contact and minimize clinicians' risk.



FULL STORY ==========================================================================
The COVID-19 pandemic presents new challenges for clinicians caring for infected patients with diabetes, according to new guidance published in
the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.


========================================================================== Hospitalized patients with COVID-19 and diabetes need to receive glucose- lowering therapy in addition to other complex medical management as a
way of minimizing risk for complications and death. However, appropriate glycemic management -- including bedside glucose monitoring and insulin administration - - requires intensive patient interactions and puts
clinicians at risk.

"This manuscript provides guidance for healthcare providers caring
for patients hospitalized for COVID-19 who also have a prior history
of diabetes or who have high blood sugar levels at the time of hospitalization," said lead author Mary T. Korytkowski, M.D., of the
University of Pittsburgh School of Medicine in Pittsburgh, Pa. "These healthcare providers are at risk for contracting COVID- 19, and while
glycemic management in the hospital improves patient outcomes, it also intensifies the amount of time with direct patient contact." Clinicians
may limit their risk of exposure by minimizing the use of IV insulin
infusions and using remote glucose monitoring devices and non-insulin
therapies when possible. Diabetes self-management by selected patients
who are knowledgeable and capable of this in the hospital also can be considered as a way of limiting direct patient interactions. Clinicians
should be aware that some medications used in treating COVID-19 patients, including glucocorticoids and hydroxychloroquine, can affect blood
glucose levels.

Other authors include Kellie Antinori-Lent of the University of Pittsburgh Medical Center Shadyside Hospital in Pittsburgh, Pa.; Andjela Drincic of
the University of Nebraska Medical Center in Omaha, Neb.; Irl B. Hirsch
of the University of Washington in Seattle, Wash.; Marie E. McDonnell
of Brigham and Women's Hospital and Harvard Medical School in Boston,
Mass.; Robert Rushakoff of the University of California in San Francisco, Calif.; and Ranganath Muniyappa of the National Institutes of Health in Bethesda, Md.


========================================================================== Story Source: Materials provided by The_Endocrine_Society. Note: Content
may be edited for style and length.


========================================================================== Journal Reference:
1. Ranganath Muniyappa, Robert Rushakoff, Marie E McDonnell, Irl
B Hirsch,
Andjela Drincic, Kellie Antinori-Lent, Mary Korytkowski. A
Pragmatic Approach to Inpatient Diabetes Management during the
COVID-19 Pandemic.

The Journal of Clinical Endocrinology & Metabolism, 2020; DOI:
10.1210/ clinem/dgaa342 ==========================================================================

Link to news story: https://www.sciencedaily.com/releases/2020/06/200605121518.htm

--- up 19 weeks, 3 days, 2 hours, 59 minutes
* Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)